Related Experiment Video
Updated: Mar 29, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
How to manage warfarin therapy
Philip A Tideman1, Rosy Tirimacco1, Andrew St John2
1Australian Point of Care Practitioners Network ; Integrated Cardiovascular Clinical Network, Country Health South Australia, Adelaide.
Insights
Warfarin is recommended for atrial fibrillation patients at risk of stroke. Patient education and self-monitoring with point-of-care testing improve outcomes for warfarin users.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Long-term warfarin therapy is crucial for patients with atrial fibrillation (AF) at risk of stroke.
- It is also indicated for recurrent venous thrombosis and prosthetic heart valves.
- Effective warfarin management requires comprehensive patient education and regular monitoring.
Purpose of the Study:
- To outline the key components of successful warfarin management.
- To emphasize the importance of patient education and monitoring strategies.
Main Methods:
- Review of current guidelines and evidence regarding warfarin therapy.
- Discussion of patient education topics: bleeding risks, diet, drug interactions, and missed doses.
- Highlighting the role of scoring systems (e.g., CHADS2) in treatment decisions.
- Mentioning age-adjusted protocols for initiating warfarin and the necessity of regular monitoring.
- Examining the benefits of self-monitoring using point-of-care testing.
Main Results:
- Patient education is pivotal for safe and effective warfarin use.
- Age-adjusted protocols facilitate rapid achievement of stable anticoagulation.
- Regular monitoring of anticoagulant effect is essential.
- Self-monitoring with point-of-care testing is associated with improved patient outcomes.
Conclusions:
- Optimizing warfarin therapy involves thorough patient education, appropriate initiation protocols, and consistent monitoring.
- Point-of-care self-monitoring may lead to better outcomes in patients on long-term warfarin treatment.
Abstract:
Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves. Patient education before commencing warfarin - regarding signs and symptoms of bleeding, the impact of diet, potential drug interactions and the actions to take if a dose is missed - is pivotal to successful use. Scoring systems such as the CHADS2 score are used to determine if patients with atrial fibrillation are suitable for warfarin treatment. To rapidly achieve stable anticoagulation, use an age-adjusted protocol for starting warfarin. Regular monitoring of the anticoagulant effect is required. Evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Embolism III: Nursing Management

